Global Cardiac Resynchronization Therapy Market

Cardiac Resynchronization Therapy Market Size, Share, Growth Analysis, By Type(CRT-Defibrillator and CRT-Pacemaker), By Application(Intraventricular desynchrony, Interventricular (V-V) desynchrony, Atrioventricular (A-V) desynchrony), By End User(Hospitals, Cardiac Care Centres, and Ambulatory Surgical Centres), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2074 | Region: Global | Published Date: July, 2024
Pages: 242 |Tables: 88 |Figures: 76

Cardiac Resynchronization Therapy Market Insights

Cardiac Resynchronization Therapy Market size was valued at USD 4.06 billion in 2019 and is poised to grow from USD 4.26 billion in 2023 to USD 6.23 billion by 2031, growing at a CAGR of 4.8% in the forecast period (2024-2031).

Increase in the incidence of target diseases, increase in the prevalence of heart attacks among the population, increase in investment in treatment, and rising healthcare spending are driving market growth. Additionally, the market will experience growth due to technical developments, modernization of healthcare equipment, growth in emerging markets, and an increase in the number of geriatric populations.

However, unfavourable healthcare reforms, increase in the risk of surgical site infections, and high device sensitivity are the main factors, among others, that will restrain market growth and pose additional challenges to the development of the cardiac resynchronization therapy market during the forecast period mentioned above.

US Cardiac Resynchronization Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 4.06 billion

Largest Segment

CRT-Defibrillator

Fastest Growth

CRT-Defibrillator

Growth Rate

4.8% CAGR

Global Cardiac Resynchronization Therapy Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Cardiac Resynchronization Therapy Market Segmental Analysis

Global Cardiac Resynchronization Therapy Market is segmented based on the Type, Application, End User and region. Based on Type Global market is segmented into CRT-Defibrillator and CRT-Pacemaker. Based on the Application into Intraventricular desynchrony, Interventricular (V-V) desynchrony, Atrioventricular (A-V) desynchrony. Based on the End User into Hospitals, Cardiac Care Centres, and Ambulatory Surgical Centres. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Cardiac Resynchronization Therapy Market Analysis by Type

The market can be segmented into Cardiac Resynchronization Therapy Defibrillators and Cardiac Resynchronization Therapy Pacemakers based on Type. The global market is divided into cardiac resynchronization therapy pacemakers and defibrillators (CRT-Ds) (CRT-Ps). In 2018, the CRT-Ds sector held the biggest market share. This is mostly attributable to the growing acceptability of CRT-Ds over pacemakers and the introduction of technologically improved devices. Additionally, the rising prevalence of the target disorders is a major factor in this market segment's growth.

Cardiac Resynchronization Therapy Market Analysis by Application

Intraventricular desynchrony has the most potential because it is estimated that a larger percentage of patients may experience intraventricular desynchrony due to cardiovascular disease and left bundle branch block. The second largest segment in the cardiac resynchronization therapy market is interventricular desynchrony. Interventricular desynchrony occurs when there is a delay or obstruction at the beginning of the right and left ventricles. Atrioventricular (A-V) desynchrony: The A-V desynchrony arises as a result of ventricle choke and trial, which can result in a condensed ventricle over time and incorrect atrial pressure location.

Global Cardiac Resynchronization Therapy Market By Type, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Cardiac Resynchronization Therapy Market Regional Insights

Due to its increasing geriatric population and growing regulatory approvals, the North American Cardiac Resynchronization Therapy market is expected to continue its leadership during the forecast period. The development can be ascribed to a number of variables, including rising consumer knowledge of the advantages of cardiovascular devices, high levels of disposable money, and the presence of a sophisticated healthcare infrastructure. Additionally, this region is home to a number of medical equipment suppliers who are engaged in the global provision of cardiovascular care. These businesses are concentrating on introducing cutting-edge products with attributes that are projected to further fuel market expansion, such as miniaturisation and longer battery life.

The market in Asia-Pacific is anticipated to grow at the fastest CAGR over the next few years. This is caused by an expanding medical infrastructure, an ageing population, favourable financial circumstances, strategic moves made by large companies, and an increase in heart problems. The adoption of new technology breakthroughs in these gadgets is accelerating in developed areas like Japan and Australia. For instance, it was discovered that despite its higher cost, remote monitoring of cardiac implanted devices, particularly in CRT/CRTDs, was quickly accepted throughout Asia-Pacific.

Global Cardiac Resynchronization Therapy Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cardiac Resynchronization Therapy Market Dynamics

Cardiac Resynchronization Therapy Market Drivers:

Increasing Prevalence of Cardiovascular Diseases

  • Approximately half of all mortality from cardiovascular diseases are caused by sudden cardiac death, despite advancements in prevention and therapy. Sudden cardiac death is still a major cause of death. The demand for cardiac resynchronization therapy devices is anticipated to rise as a result of the rising prevalence of heart illnesses and their risk factors. Heart failure is one of the leading causes of death in the world.

Rising Sedentary Lifestyle 

  • Physical inactivity is a major public health concern because it is connected to the second-highest number of deaths in the U.S., after smoking. Morbid obesity and numerous other chronic conditions, including heart issues and diabetes, can be brought on by physical inactivity. It has frequently been noted that prolonged periods of inactivity worsen the symptoms of CVD in diabetic and atherosclerotic patients who are otherwise physically active. Cardiovascular diseases like angina, myocardial infarction, and stroke are major effects of this lifestyle.

Cardiac Resynchronization Therapy Market Restraint:

Product Recall

  • Boston Scientific Corporation started the INGENIO family of pacemakers and CRT-Ps recall in June 2022. ADVANTIO DR EL, INGENIO DR EL, and VITALIO DR EL are a few of them. Between November 2016 and August 2022, the recalled devices were distributed after being produced between September 2016 and December 2018. In the United States, some 48,000 gadgets were recalled. The possibility of the gadget entering safety mode led to the recall.

Request Free Customization of this report to help us to meet your business objectives.

Cardiac Resynchronization Therapy Market Competitive Landscape

The competitive landscape for the cardiac resynchronization therapy market provides information by competitor. Included information includes a business overview, financials, revenue generated, market potential, investments in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launches, product breadth and depth, and application dominance. Only the companies' market focus on cardiac resynchronization therapy is covered by the data points mentioned above.

Cardiac Resynchronization Therapy Market Top Player's Company Profiles

  • Medtronic
  • Abbott Laboratories

  • Boston Scientific Corporation

  • Biotronik SE & Co. KG

  • LivaNova PLC

  • St. Jude Medical, Inc.

  • EBR Systems, Inc.

  • Cardiac Dimensions, Inc.

  • Sorin Group

  • Cook Medical, Inc.

  • Osprey Medical, Inc.

  • BioVentrix, Inc.

  • MicroPort Scientific Corporation

  • Endologix, Inc.

  • InspireMD, Inc.

  • Integer Holdings Corporation

  • Inari Medical, Inc.

  • Syncardia Systems, Inc.

  • AngioDynamics, Inc.

  • Cardiva Medical, Inc.

Cardiac Resynchronization Therapy Market Recent Developments

  • In March 2022, Abbott acquired Walk Vascular, LLC, a company that makes medical devices for minimally intrusive mechanical target thrombectomy systems. The organization's line of endovascular products was expanded by this acquisition.
  • In June 2022, Baylis Medical Company, Inc. will be purchased by Boston Scientific Corporation. This acquisition, valued at USD 1.76 billion, expanded its core portfolios in electrophysiology and the heart.

Cardiac Resynchronization Therapy Key Market Trends

  • Patients with heart failure who are also at high risk for sudden cardiac death should use CRT - Defibrillators (CRT-D). A CRT-D device treats sluggish heart rhythms similarly to a typical pacemaker, but it additionally sends tiny electrical impulses to the left and right ventricles to encourage coordinated contraction. Your heart will pump more effectively as a result. Arrhythmias, which are dangerously rapid heartbeats that might cause a sudden cardiac arrest, can also be treated with a CRT-D device. A shock is given to the heart if the equipment detects dangerously rapid heartbeats. Defibrillation, or this shock, puts an end to the irregular rhythm. The dangerously rapid pulse could result in death in only minutes without this life-saving treatment. Through new smartphone connectivity and connected applications, the devices provide new opportunities for patient engagement and remote monitoring. A patient-favourite design, longer battery life, and MRI compatibility are additional advantages. Due to the rising incidence and mortality of cardiovascular diseases, these devices have recently increased.

Cardiac Resynchronization Therapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global cardiac resynchronization therapy market analysis, the market is anticipated to expand favourably as a result of the growing elderly population, which represents the population group most susceptible to heart failure, the rising prevalence of cardiovascular diseases like coronary artery disease, which may also serve as a risk factor for heart failure, and the rising prevalence of lifestyle disorders like hypertension and diabetes, which may have long-term effects on heart health.

Report Metric Details
Market size value in 2023 USD 4.06 billion
Market size value in 2031 USD 6.23 billion
Growth Rate 4.8%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • CRT-Defibrillator and CRT-Pacemaker
  • Application
    • Intraventricular desynchrony, Interventricular (V-V) desynchrony, Atrioventricular (A-V) desynchrony
  • End User
    • Hospitals, Cardiac Care Centres, and Ambulatory Surgical Centres
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic
  • Abbott Laboratories

  • Boston Scientific Corporation

  • Biotronik SE & Co. KG

  • LivaNova PLC

  • St. Jude Medical, Inc.

  • EBR Systems, Inc.

  • Cardiac Dimensions, Inc.

  • Sorin Group

  • Cook Medical, Inc.

  • Osprey Medical, Inc.

  • BioVentrix, Inc.

  • MicroPort Scientific Corporation

  • Endologix, Inc.

  • InspireMD, Inc.

  • Integer Holdings Corporation

  • Inari Medical, Inc.

  • Syncardia Systems, Inc.

  • AngioDynamics, Inc.

  • Cardiva Medical, Inc.

Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cardiac Resynchronization Therapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cardiac Resynchronization Therapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cardiac Resynchronization Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cardiac Resynchronization Therapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cardiac Resynchronization Therapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cardiac Resynchronization Therapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cardiac Resynchronization Therapy Market size was valued at USD 4.06 billion in 2019 and is poised to grow from USD 4.26 billion in 2023 to USD 6.23 billion by 2031, growing at a CAGR of 4.8% in the forecast period (2024-2031).

The competitive landscape for the cardiac resynchronization therapy market provides information by competitor. Included information includes a business overview, financials, revenue generated, market potential, investments in R&D, new market initiatives, presence, production sites and facilities, production capacities, company strengths and weaknesses, product launches, product breadth and depth, and application dominance. Only the companies' market focus on cardiac resynchronization therapy is covered by the data points mentioned above. 'Medtronic', ' Abbott Laboratories ', ' Boston Scientific Corporation ', ' Biotronik SE & Co. KG ', ' LivaNova PLC ', ' St. Jude Medical, Inc. ', ' EBR Systems, Inc. ', ' Cardiac Dimensions, Inc. ', ' Sorin Group ', ' Cook Medical, Inc. ', ' Osprey Medical, Inc. ', ' BioVentrix, Inc. ', ' MicroPort Scientific Corporation ', ' Endologix, Inc. ', ' InspireMD, Inc. ', ' Integer Holdings Corporation ', ' Inari Medical, Inc. ', ' Syncardia Systems, Inc. ', ' AngioDynamics, Inc. ', ' Cardiva Medical, Inc. '

Approximately half of all mortality from cardiovascular diseases are caused by sudden cardiac death, despite advancements in prevention and therapy. Sudden cardiac death is still a major cause of death. The demand for cardiac resynchronization therapy devices is anticipated to rise as a result of the rising prevalence of heart illnesses and their risk factors. Heart failure is one of the leading causes of death in the world.

Patients with heart failure who are also at high risk for sudden cardiac death should use CRT - Defibrillators (CRT-D). A CRT-D device treats sluggish heart rhythms similarly to a typical pacemaker, but it additionally sends tiny electrical impulses to the left and right ventricles to encourage coordinated contraction. Your heart will pump more effectively as a result. Arrhythmias, which are dangerously rapid heartbeats that might cause a sudden cardiac arrest, can also be treated with a CRT-D device. A shock is given to the heart if the equipment detects dangerously rapid heartbeats. Defibrillation, or this shock, puts an end to the irregular rhythm. The dangerously rapid pulse could result in death in only minutes without this life-saving treatment. Through new smartphone connectivity and connected applications, the devices provide new opportunities for patient engagement and remote monitoring. A patient-favourite design, longer battery life, and MRI compatibility are additional advantages. Due to the rising incidence and mortality of cardiovascular diseases, these devices have recently increased.

Due to its increasing geriatric population and growing regulatory approvals, the North American Cardiac Resynchronization Therapy market is expected to continue its leadership during the forecast period. The development can be ascribed to a number of variables, including rising consumer knowledge of the advantages of cardiovascular devices, high levels of disposable money, and the presence of a sophisticated healthcare infrastructure. Additionally, this region is home to a number of medical equipment suppliers who are engaged in the provision of cardiovascular care. These businesses are concentrating on introducing cutting-edge products with attributes that are projected to further fuel market expansion, such as miniaturisation and longer battery life.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cardiac Resynchronization Therapy Market

Product ID: SQMIG35D2074

$5,300
BUY NOW GET FREE SAMPLE